GlycoNet start-up receives up to $4 million US investment to advance regenerative medicine
(Canadian Glycomics Network) GlycoNet scientists Drs. Robert Ben and Jason Acker, who are revolutionizing the cryopreservation of cells, tissues and organs for human and veterinary therapies, have secured a $2-million USD equity investment for PanTHERA CryoSolutions (PanTHERA), a Canadian biotechnology start-up that they co-founded. The investment came from US-based investor Casdin Capital and bioproduction tools supplier BioLife Solutions Inc (NASDAQ: BLFS).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news